Skip to main content

Drug Interactions between mecamylamine and Virtrate-3

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

mecamylamine potassium citrate

Applies to: mecamylamine and Virtrate-3 (citric acid/potassium citrate/sodium citrate)

MONITOR: Alkalinization of the urine can decrease the renal elimination of mecamylamine. A more pronounced and prolonged antihypertensive action may result.

MANAGEMENT: Blood pressure should be closely monitored. It may be necessary to decrease mecamylamine dosage.

References

  1. Allanby KD, Trounce JR "Excretion of mecamylamine after intravenous and oral administration." Br Med J 2 (1957): 1219-21

Switch to consumer interaction data

Moderate

mecamylamine sodium citrate

Applies to: mecamylamine and Virtrate-3 (citric acid/potassium citrate/sodium citrate)

MONITOR: Alkalinization of the urine can decrease the renal elimination of mecamylamine. A more pronounced and prolonged antihypertensive action may result.

MANAGEMENT: Blood pressure should be closely monitored. It may be necessary to decrease mecamylamine dosage.

References

  1. Allanby KD, Trounce JR "Excretion of mecamylamine after intravenous and oral administration." Br Med J 2 (1957): 1219-21

Switch to consumer interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer